Infection and Immunity · 1998 · 161 citations · 25 references
Life SciencesImmunologyPharmacologyImmunopharmacologyNutritional ImmunologySepsisAnimal Models In PharmacologyNutritional Modulation Of CytokinesSepsis PathophysiologySeptic ShockBovine Serum AlbuminClinical SymptomsEndotoxin ToxicityEndotoxin-mediated DiseaseLactoferrin ActivityLactoferrin UtilizationMonocyte-derived MacrophagesPiglet Nutrition
The unique germfree, colostrum-deprived, immunologically "virgin" piglet model was used to evaluate the ability of lactoferrin (LF) to protect against lethal shock induced by intravenously administered endotoxin. Piglets were fed LF or bovine serum albumin (BSA) prior to challenge with intravenous Escherichia coli lipopolysaccharide (LPS), and temperature, clinical symptoms, and mortality were tracked for 48 h following LPS administration. Prefeeding with LF resulted in a significant decrease in piglet mortality compared to feeding with BSA (16.7 versus 73.7% mortality, P < 0.001). Protection against the LPS challenge by LF was also correlated with both resistance to induction of hypothermia by endotoxin and an overall increase in wellness, as quantified by a toxicity score developed for these studies. In vitro studies using a flow cytometric assay system demonstrated that LPS binding to porcine monocytes was inhibited by LF in a dose-dependent fashion, suggesting that the mechanism of LF action in vivo may be inhibition of LPS binding to monocytes/macrophages and, in turn, prevention of induction of monocyte/macrophage-derived inflammatory-toxic cytokines.
25
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Samuel D. Wright, Robert Ramos, Peter S. Tobias et al. · Science · 1990 · 4K citations
Anders Waage, P Brandtzæg, Alfred Halstensen et al. · The Journal of Experimental Medicine · 1989 · 1.2K citations · Full text